C-reactive protein is a substance which appears in the blood in the course of a variety of disease processes. The existence of this protein in serum was first recognized as a result of its property of reacting to form a precipitate in the presence of the somatic C polysaccharide of Pneumococcus (1) , and this reaction is responsible for the name which is at present used for the protein. Since the original description of the reaction, a number of papers have appeared concerning the purification and properties of this protein, and the range of diseases in which it is present in the blood (2) (3) (4) (5) (6) .
The determination of C-reactive protein in the blood as a measure of the activity of the disease process in acute rheumatic fever has been described by Anderson and McCarty (7) . In this instance, a specific rabbit antiserum to human Creactive protein was employed to detect the presence of the protein in patients' sera by means of a precipitin test, and the results of this test were correlated with clinical and other laboratory data in a series of 45 patients with acute rheumatic fever. Like the erythrocyte sedimentation rate and the white blood cell count, the test for C-protein is not a diagnostic test for rheumatic fever, since it is positive in other infectious and non-infectious diseases. However, in this series of cases it appeared to be a more sensitive index of disease activity than any other that was available.
The antigen-antibody test for estimating C-reactive protein is extremely sensitive in detecting small amounts of the substance in serum, but the procedure used is at best only semi-quantitative. The results are recorded on the basis of the volume of precipitate formed, ranging from zero in the absence of reaction to + + + + + + in the case of a maximal reaction. It is obvious that readings of this sort may not be the same when made by different observers, and furthermore different lots of antiserum vary in the amount of precipitable antibody which they contain. In the present study an attempt has been made to obtain a more quantitative estimate of the amount of C-protein present in various sera, and to correlate the quantitative data with the results of the precipitin reaction.
The general use of the C-protein precipitin test with rabbit antiserum as a clinical laboratory test in rheumatic fever is at present limited because of the difficulties involved in obtaining pure Cprotein preparations in quantities which allow large scale production of rabbit antiserum. An alternative to the use of rabbit antiserum for the detection of the C-reactive protein in serum is the original precipitation reaction which employs the relatively easily prepared C polysaccharide of the Pneumococcus (8) (3, 4) . This preparation was almost completely free of normal human serum proteins. The antiserum reacted slightly with normal human serum, and the cross-reacting antibody was completely removed by adsorption with dried normal human serum protein.
Precipitin test with antiserum. The precipitin tests with antiserum were carried out in capillary tubes according to the procedure described by Anderson and McCarty (7) . This method is based on the capillary precipitin technique for serologic typing of group A streptococci described by Swift, Wilson and Lancefield (9) .
Pneumococcal Cx polysaccharide. This polysaccharide was prepared by rapid lysis and deproteinization of the pneumococcal cells, as recently described by Anderson and McCarty (10) . It is identical with classical C polysaccharide in the sensitivity of its reaction with human C-reactive protein, and either one can be used to react with and remove the C-protein from serum.
The Two aspects of the validity of this quantitative procedure were checked by serological methods. First, although previous experience indicated that a single concentration of Cx polysaccharide (0.1 mg./cc.) could serve as the precipitant throughout the entire range of C-protein concentrations expected in sera, this was further checked by submitting the serum supernatants (after removal of the C-protein-polysaccharide precipitates) to the sensitive antibody test for C-protein. It was found that the 0.1 mg./cc. solution of polysaccharide removed practically all of the C-protein from sera containing the highest concentrations and showed no evidence of pro-.oning with sera containing smaller amounts. Secondly, it was important to determine whether the washed Cprotein-polysaccharide precipitates contained appreciable quantities of serum proteins other than C-reactive protein. This point was investigated by testing the redissolved precipitate by the precipitin method with high-titered rabbit antiserum prepared against normal human serum. Only negative or trace reactions were obtained in these tests, indicating that normal serum proteins were probably not present in amounts sufficient to affect the spectrophotometric readings.
The results obtained by this quantitative procedure do not appear to be influenced by the presence of antibody to pneumococcal C polysaccharide. This antibody was shown by Heidelberger, MacLeod, Kaiser, and Robinson to be present in most human sera in significant amounts (11) . The fact that antibody does not interfere with the measurement of C-reactive protein is probably best explained by the following considerations: In the quantitative measurement of C antibody, Heidelberger and his associates found it necessary to use long periods of refrigeration (eight days or longer) to obtain complete precipitation by the polysaccharide, while in the case of C-reactive protein refrigeration overnight is sufficient; and furthermore if antigen-antibody precipitates were formed in the course of the procedure described above, they would not redissolve in the citrate solution and would be removed by centrifugation before the spectrophotometric measurement was carried out.
Standardization of the spectrophotownetric measurement of C-reactive protein. For the purpose of calculating the actual protein concentrations represented by the optical density measurements, a standard curve was prepared, using a large lot of purified C-reactive protein on which nitrogen analyses were carried out. The purified C-protein was obtained from 615 cc. of thoracentesis fluid from a patient with lymphosarcoma. Preliminary study of a sample of this fluid showed that the greater part of the C-protein which it contained was bound to phospholipid; and since the phosphorus and nitrogen contributed by the phospholipid would have influenced the quantitative results on elementary analysis of the purified protein, a de- Figure 1 shows the relationship between the concentrations of C-reactive protein and its adsorption at 280 m#.
It has previously been determined that crystalline C-reactive protein contains 14.66% nitrogen (12) , and the values for protein concentration are calculated from the nitrogen values on the basis of this figure.
RESULTS
Comparison of the sensitisity of the two clinical tests for measuring C-protein in patients' sera. Consecutive weekly bleedings from 18 patients hospitalized for acute rheumatic fever were tested for the presence of C-reactive protein both by the precipitin test with specific antiserum, and by the ring test with Cx carbohydrate. The results obtained with both techniques on a total of 200 sera are shown in Table I .
It is evident from the data that the test system using the antiserum is definitely and consistently more sensitive than that in which the Cx carbohydrate is employed. The ring test with carbohydrate cannot be used as a reliable indicator for the detection of the C-protein in sera which give less than a ++ ± precipitin reaction with the antiserum. As shown by the quantitative data in Table IV In an attempt to increase the sensitivity of the carbohydrate ring test system, the carbohydrate solutions were made up in 1 % crystalline bovine albumin solution and in 1 % solution of human serum fraction V (13). It was found that the use of albumin intensified the ring with sera known to be reactive but did not cause the formation of visible reactions with sera that failed to give a positive ring test with the carbohydrate in saline.
From the point of view of clinical application, the lower sensitivity of the test with C polysaccharide greatly reduces its usefulness. This is unfortunate since the availability of C polysaccharide would make this procedure more feasible for general use than the test requiring specific antiserum. However, in the results described by Anderson and McCarty (7) and in subsequent studies in this laboratory, the determination of C-reactive protein in the evaluation of rheumatic activity is frequently most helpful in those cases in which the sera fall in the lower range of the precipitin reaction where the ring test with the polysaccharide is not reliable. In cases with more marked activity of the disease process, where both tests are strongly positive, other laboratory as well as clinical evidence of activity is usually available.
In addition to the studies on sera from rheumatic fever patients, precipitin tests have been carried out with sera from patients with a variety of other diseases, and in some instances it appears that the concentration of C-protein in the serum rarely, if ever, reaches levels that would be detectable with the C polysaccharide ring test. An interesting example is provided by studies on viral hepatitis. Havens, Eichman and Knowlton (14) have recently reported the failure to demonstrate the presence of C-protein by means of the C carbohydrate test in the sera of 90 patients with this disease. These workers called attention to the fact that the use of antiserum might have given different results, and this possibility has been investigated in this laboratory by testing 68 sera from 18 patients with viral hepatitis in the Hospital of The Rockefeller Institute. Thirty-eight of these sera gave positive precipitin reactions with the antiserum, but, as can be seen from the data presented in Table II , none of these reactions was of sufficient intensity so that a reaction with C carbohydrate would be expected. The incidence of positive precipitin reactions in relation to the duration of the disease is recorded in Table III , and it is obvious that the occurrence of C-protein in the serum is not limited to any particular phase of the disease. It appears that the occurrence of C-protein in the blood is a common, though not invariable, event in viral hepatitis. Quantitative studies of the C-reactive protein in the serum of patients with acute rheumatic fever. Quantitative determinations of the C-reactive protein were done on the sera from serial bleedings on six patients with acute rheumatic fever. The concentration of the protein was calculated from the optical density readings by the use of the standard curve and was expressed in terms of mg. of protein per cc. of serum.
In Table IV As indicated by these data, 1 cc. of a serum giving + + + + + + precipitin reaction contains over 0.3 mg. of this abnormal serum protein. Sera obtained from patients during the most active stage of acute rheumatic fever give marked reactions ranging from + + + + to + + + + + + in precipitin tests with C-protein antiserum. On the basis of the quantitative data presented in Table IV , precipitin reactions of this order indicate that there is an appreciable total amount of C-protein in the circulating blood at the height of the disease. As recovery progresses this protein is present in decreasing amounts until it disappears from the blood completely, often before the erythrocyte sedimentation rate has returned to normal (7) .
The quantitative fluctuations in C-reactive protein in the serum during the course of rheumatic fever are illustrated graphically by the charts of two patients given in Figures 2 and 3 . on patient J. D., illustrates a simple monocyclic pattern of rheumatic fever with major manifestations of fever, polyarthritis, and carditis. The C-reactive protein in this patient showed a sharp uninterrupted drop to zero from the high level of 0.360 mg./cc. present during the most acute phase of the illness. In Figure 3 the variations of C-protein concentration in the blood are illustrated in a case of streptococcal pharyngitis which was followed by a recurrence of rheumatic fever. This patient, P. Q. of C-protein concentration is of interest with respect to the evaluation of the latent interval between the streptococcal infection and the onset of rheumatic fever. Although C-protein did not completely disappear from the blood in this instance, it had fallen sharply from 0.27 mg./cc. to 0.04 mg./ cc. in seven days before the appearance of symptoms of rheumatic fever. This rate of fall is comparable to that seen in certain cases of uncomplicated streptococcal infection. It would appear from this and other data, therefore, that there is nothing in the pattern of C-protein response which makes it possible to predict the imminence of rheumatic fever as a complication of streptococcal disease.
DISCUSSION
As a result of the use of the quantitative procedure for the estimation of C-reactive protein, it is now possible to give reasonably accurate values for the concentration of this substance in the blood during various disease states. While the spectrophotometric method is not suggested as a routine clinical procedure, it appears to have value in the study of certain cases of special interest in which more exact data concerning the fluctuations in concentration of C-protein are desirable. Moreover, the quantitative data allow a more precise comparison of the sensitivity of the two tests which have clinical applicability, and it is apparent that the test with specific antibody is greatly superior to that with the C polysaccharide. The ring test with C polysaccharide is not consistently positive at concentrations of C-protein below 0.1 mg./cc., while the antibody test will detect the presence of less than 0.01 mg./cc. In view of this fact, it is clear that at present the antibody procedure is the method of choice whenever the concentration of C-protein in the blood is to be used as a reflection of the activity of a disease process. SUMMARY AND CONCLUSION 1. A quantitative method for the determination of C-reactive protein in human serum is described. Although absent from normal serum, the protein has been shown to reach concentrations above 0.33 mg./cc. in acute rheumatic fever.
2. The C-reactive protein may be detected semiquantitatively by its reaction with the pneumococcal C polysaccharide or by a precipitin test with a specific rabbit antiserum. The sensitivities of these two methods have been compared and it is shown that the reaction with C polysaccharide is not reliable at serum C-protein concentrations below 0.1 mg./cc., while the rabbit antiserum gives positive reactions in the presence of less than 0.01 mg./cc. It is concluded that the C polysaccharide test cannot replace the antibody test in the clinical procedure in which C-protein is determined as a measure of rheumatic activity.
3. The sera of some patients with viral hepatitis contain C-reactive protein in concentrations high enough to be detected with the antiserum but too low to be detected by a visible reaction with the Cx polysaccharide. The presence of the C-reactive protein in sera from patients with viral hepatitis is not limited to the initial acute phase of the disease.
